Crispr Therapeutics Ag (CRSP)
33.94 +0.80 (+2.41%) 10:55 ET [NASDAQ]
33.87 x 100 34.05 x 1
Realtime by (Cboe BZX)
33.87 x 100 34.05 x 1
Realtime 32.68 -0.46 (-1.39%) 09:28 ET
for Wed, Apr 2nd, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 298,257 | 389,477 | 211,885 | 923,031 | 1,168,620 |
| Marketable Securities | 1,605,569 | 1,304,215 | 1,603,433 | 1,456,098 | 521,713 |
| Receivables | 25,000 | 200,000 | N/A | 305 | 144 |
| TOTAL | $1,937,132 | $1,908,078 | $1,853,026 | $2,417,513 | $1,716,620 |
| Non-Current Assets | |||||
| PPE Net | 134,093 | 151,945 | 163,634 | 137,575 | 42,160 |
| Investments And Advances | 0 | 1,973 | 53,130 | 0 | 0 |
| Intangibles | 0 | 16 | 71 | 125 | 180 |
| Other Non-Current Assets | 170,809 | 167,559 | 173,196 | 196,664 | 69,006 |
| TOTAL | $304,902 | $321,493 | $390,031 | $334,364 | $111,346 |
| Total Assets | $2,242,034 | $2,229,571 | $2,243,057 | $2,751,877 | $1,827,966 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,709 | 38,147 | 27,428 | 14,816 | 9,094 |
| Accrued Expenses | 41,523 | 45,773 | 77,817 | 91,727 | 64,255 |
| Other current liabilities | 10,417 | 5,141 | 20 | 171 | 7,207 |
| TOTAL | $87,782 | $108,791 | $121,107 | $119,883 | $94,259 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,845 | 4,105 | N/A | 1,011 | 2,341 |
| aiOther Non-Current Liabilities | 209,849 | 223,965 | 234,148 | 220,211 | 69,473 |
| TOTAL | $222,172 | $237,977 | $246,471 | $232,534 | $69,473 |
| Total Liabilities | $309,954 | $346,768 | $367,578 | $352,417 | $163,732 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 85,774 | 80,276 | 78,647 | 77,068 | 75,429 |
| Common Shares | 2,698 | 2,497 | 2,441 | 2,391 | 2,277 |
| Retained earnings | -1,365,952 | -999,700 | -846,090 | -195,915 | -573,576 |
| Other shareholders' equity | 1,778 | 1,851 | -15,710 | -5,130 | -146 |
| TOTAL | $1,932,080 | $1,882,803 | $1,875,479 | $2,399,460 | $1,664,234 |
| Total Liabilities And Equity | $2,242,034 | $2,229,571 | $2,243,057 | $2,751,877 | $1,827,966 |